Free Trial

Butterfly Network (BFLY) Competitors

Butterfly Network logo
$2.34 -0.02 (-0.64%)
Closing price 04/17/2025 03:58 PM Eastern
Extended Trading
$2.36 +0.02 (+1.07%)
As of 04/17/2025 06:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BFLY vs. LIVN, LMAT, ENOV, NVCR, CNMD, WRBY, CDRE, KMTS, LQDA, and TNDM

Should you be buying Butterfly Network stock or one of its competitors? The main competitors of Butterfly Network include LivaNova (LIVN), LeMaitre Vascular (LMAT), Enovis (ENOV), NovoCure (NVCR), CONMED (CNMD), Warby Parker (WRBY), Cadre (CDRE), Kestra Medical Technologies (KMTS), Liquidia (LQDA), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry.

Butterfly Network vs.

LivaNova (NASDAQ:LIVN) and Butterfly Network (NYSE:BFLY) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, community ranking, valuation, institutional ownership and profitability.

LivaNova has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500. Comparatively, Butterfly Network has a beta of 2.6, indicating that its share price is 160% more volatile than the S&P 500.

97.6% of LivaNova shares are held by institutional investors. Comparatively, 37.8% of Butterfly Network shares are held by institutional investors. 0.3% of LivaNova shares are held by company insiders. Comparatively, 27.3% of Butterfly Network shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, LivaNova had 6 more articles in the media than Butterfly Network. MarketBeat recorded 12 mentions for LivaNova and 6 mentions for Butterfly Network. LivaNova's average media sentiment score of 1.29 beat Butterfly Network's score of 1.00 indicating that LivaNova is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LivaNova
9 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
Butterfly Network
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

LivaNova received 398 more outperform votes than Butterfly Network when rated by MarketBeat users. However, 70.00% of users gave Butterfly Network an outperform vote while only 69.71% of users gave LivaNova an outperform vote.

CompanyUnderperformOutperform
LivaNovaOutperform Votes
405
69.71%
Underperform Votes
176
30.29%
Butterfly NetworkOutperform Votes
7
70.00%
Underperform Votes
3
30.00%

LivaNova has a net margin of 1.91% compared to Butterfly Network's net margin of -129.25%. LivaNova's return on equity of 13.81% beat Butterfly Network's return on equity.

Company Net Margins Return on Equity Return on Assets
LivaNova1.91% 13.81% 7.07%
Butterfly Network -129.25%-42.68%-30.31%

LivaNova currently has a consensus target price of $61.17, indicating a potential upside of 71.91%. Butterfly Network has a consensus target price of $3.00, indicating a potential upside of 28.48%. Given LivaNova's higher possible upside, analysts clearly believe LivaNova is more favorable than Butterfly Network.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.88
Butterfly Network
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

LivaNova has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.25B1.54$17.55M$1.1431.21
Butterfly Network$82.06M6.91-$133.70M-$0.33-7.08

Summary

LivaNova beats Butterfly Network on 14 of the 19 factors compared between the two stocks.

Get Butterfly Network News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFLY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BFLY vs. The Competition

MetricButterfly NetworkX IndustryMedical SectorNYSE Exchange
Market Cap$567.23M$10.76B$5.30B$18.41B
Dividend YieldN/A2.07%5.12%4.20%
P/E Ratio-5.0816.2821.8631.07
Price / Sales6.917.88380.5426.55
Price / CashN/A11.9038.2617.53
Price / Book2.201.946.454.30
Net Income-$133.70M$344.53M$3.22B$1.02B
7 Day Performance-4.50%1.09%2.85%1.42%
1 Month Performance-10.02%-11.71%-8.67%-7.33%
1 Year Performance184.76%6.63%11.46%2.27%

Butterfly Network Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BFLY
Butterfly Network
2.4712 of 5 stars
$2.34
-0.6%
$3.00
+28.5%
+185.0%$567.23M$82.06M-5.08460News Coverage
LIVN
LivaNova
3.5663 of 5 stars
$35.46
+4.4%
$61.17
+72.5%
-31.4%$1.93B$1.25B84.432,900Positive News
Gap Down
LMAT
LeMaitre Vascular
3.1246 of 5 stars
$83.78
+1.2%
$95.25
+13.7%
+36.9%$1.89B$219.86M45.78490Positive News
ENOV
Enovis
2.4301 of 5 stars
$32.28
+0.8%
$58.50
+81.2%
-43.3%$1.84B$2.11B-14.746,800Gap Up
NVCR
NovoCure
3.3317 of 5 stars
$16.55
+0.3%
$34.50
+108.5%
+29.3%$1.82B$605.22M-11.821,320Upcoming Earnings
Analyst Forecast
Analyst Revision
News Coverage
CNMD
CONMED
4.737 of 5 stars
$50.91
-1.6%
$77.20
+51.6%
-33.3%$1.57B$1.31B12.014,100News Coverage
Positive News
Gap Down
WRBY
Warby Parker
3.3518 of 5 stars
$14.92
+0.8%
$22.71
+52.2%
+17.8%$1.55B$771.32M-55.263,030Analyst Upgrade
News Coverage
Gap Up
CDRE
Cadre
3.3533 of 5 stars
$31.24
+1.5%
$37.00
+18.4%
-7.3%$1.27B$567.56M37.642,240Positive News
KMTS
Kestra Medical Technologies
N/A$23.83
-1.9%
$27.67
+16.1%
N/A$1.18B$45.82M0.00300Earnings Report
Analyst Forecast
Quiet Period Expiration
News Coverage
LQDA
Liquidia
2.2679 of 5 stars
$13.83
+2.7%
$26.63
+92.5%
-1.0%$1.18B$14.00M-8.4850Insider Trade
Gap Up
TNDM
Tandem Diabetes Care
4.2129 of 5 stars
$17.03
-0.2%
$43.88
+157.7%
-46.9%$1.13B$940.20M-8.822,600Positive News
Gap Down

Related Companies and Tools


This page (NYSE:BFLY) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners